What if the global road system had untapped potential to produce clean energy from the Sun? The latest renewable energy innovation may be designing solar panels that can fit existing transportation infrastructure.
Three carbon capture stories this week: UC Berkeley researchers develop a material that is a direct air capture sponge, the finding of Chonkus, a cyanobacteria that can gobble up CO2, and progress for Canada's oil sands Pathway Alliance.
Ask a person in Florida or Asheville, North Carolina, and they will tell you that the climate is changing. But the latest UN Emissions Gap Report shows that governments continue to procrastinate about action to address global warming. The result is we are heading to a 3.1 Celsius (5.6 Fahrenheit) rise by 2100.
The Toyota Research Institute (TRI) doing cutting-edge research on robotics this week joined in partnership with Boston Dynamics to have the latter use TRI's Large Behaviour Models (LBMs) and diffusion policy methodology with Atlas, a general-purpose humanoid robot.
Applying virtual twin simulations is the next stage in the evolution of personalized medical treatment where your body will have a digital twin for doctors to monitor your health and catch changes that could become life threatening.
Red blood cells aren't like other cells in our bodies. They don't have a nucleus. Blood types are a result of distinct antigens absent or found on the surfaces of red blood cells. Blood screening for matching now involves screening for 47 different blood groups.
Why as we come to the end of four years for the COVID-19 pandemic are so many hesitant to keep up to date with vaccination? The reasons are many including feared side effects, safety and efficacy, and vaccine complacency and exhaustion. But the worst reason is misinformation spread by so-called experts, celebrities and authority figures.
What if a flu vaccine could protect us beyond one year from all influenza strains, those in the present and future? That's where work at the Cleveland Clinic's Lerner Research Institute may yield a universal vaccine candidate that is showing great results in mice studies and will be in human clinical trials in one to three years.
David P. Strachan, an immunologist, argued that early childhood exposure to viruses and microbes that make us sick ultimately strengthens our immune systems and protects us from developing allergies and autoimmune diseases. He called this the hygiene hypothesis.
Recent Comments